Chronic inflammatory diseases – manufacturing of a specific drug

The invention on hand deals with a drug against chronic inflammatory diseases which is specific for a cell or tissue type, a particular disease or a particular disease stage. Proteins and nucleic acids that are specific for a disease, a cell type, a tissue or a disease stage are identified with regard to their changed expression pattern. The respective nucleic acids are analyzed in consideration of their suitability as targets for DNAzymes oder siRNA. Active specific DNAzymes and siRNA are designed thereupon, binding to target sequences and cleaving them. In doing so, the current invention provides a drug against chronic inflammatory and autoimmune diseases.

The drug preferentially affects the points of intervention of the complex cascade of immunologic and cytologic misregulations underlying chronic inflammation and autoimmune reactions. The regulation of the differentiation of the transcription factors involved in the cascade, as e.g. the TH2 cell specific transcription factor GATA-3 or the TH1 cell specific transcription factor T-bet, is indicative of such a point of intervention.

Further Information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Contact
Dr. Peter Stumpf

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Chimpanzee in a tropical forest demonstrating genetic adaptations for survival.

Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans

The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…

Fiber-rich foods promoting gut health and anti-cancer effects.

You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation

The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…

RNA-binding protein RbpB regulating gut microbiota metabolism in Bacteroides thetaiotaomicron.

Trust Your Gut—RNA-Protein Discovery for Better Immunity

HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…